These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14440551)

  • 21. The clinical intoxication induced by a heparinoid.
    FIELD JB; ATTYAH AM; RAMSAY GD; LEVITT H
    Am J Med Sci; 1961 May; 241():637-44. PubMed ID: 13699356
    [No Abstract]   [Full Text] [Related]  

  • 22. [The increase of thrombin inhibitor in the blood after percutaneous administration of a heparinoid].
    WITTE S; BRESSEL D
    Klin Wochenschr; 1960 May; 38():501. PubMed ID: 13845470
    [No Abstract]   [Full Text] [Related]  

  • 23. Characterization of anticoagulant heparinoids by immunoprofiling.
    Wijnhoven TJ; van de Westerlo EM; Smits NC; Lensen JF; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
    Glycoconj J; 2008 Feb; 25(2):177-85. PubMed ID: 17909966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Favorable and unfavorable experiences in intramuscular treatment with the heparinoid Ro 1-8307].
    CEJKA V; de VRIES L
    Folia Med Neerl; 1962 Jul; 5():137-41. PubMed ID: 13877618
    [No Abstract]   [Full Text] [Related]  

  • 25. On the effect of alimentary lipemia and a natural heparinoid on the fibrinolytic system of man.
    KONTTINEN Y
    Scand J Clin Lab Invest; 1962; 14():87-99. PubMed ID: 14458289
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of heparinoids on the blood sugar level and blood lipids in diabetes mellitus].
    Markoski S
    Vutr Boles; 1977; 16(6):52-8. PubMed ID: 74910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux.
    Koch P
    Contact Dermatitis; 2003 Dec; 49(6):276-80. PubMed ID: 15025697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. THE ANTICOAGULANT AND METHACHROMATIC PROPERTIES OF THE HEPARINOID G31150 IN DOGS.
    JARRETT CL; JAQUES LB
    Can J Physiol Pharmacol; 1964 Jan; 42():93-100. PubMed ID: 14324157
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of a heparinoid extract on the total serum cholesterol and the alpha and beta lipoprotein fractions].
    MANCINI M; D'ANDREA L; ORIENTE P; GUERRIERI R; MAIORANO G
    Minerva Med; 1960 Feb; 51():389-91. PubMed ID: 14420509
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effect of aldosterone and aldosterone antagonists in patients with hypoaldosteronism caused by heparinoid].
    CEJKA V; de VRIES L; van DAATSELLAR J; BORST JG
    Ned Tijdschr Geneeskd; 1962 Mar; 106():617-20. PubMed ID: 13877617
    [No Abstract]   [Full Text] [Related]  

  • 31. [COMPARISON BETWEEN THE THERAPEUTIC ACTION OF ANTICOAGULANTS AND OTHER DRUGS IN OCCLUSION OF THE CENTRAL RETINAL VEIN].
    PANDOLFI M; BROGI M; LAMPIS R
    Ann Ottalmol Clin Ocul; 1963 Dec; 89():926-30. PubMed ID: 14118574
    [No Abstract]   [Full Text] [Related]  

  • 32. [Opportunity to use heparinoid or dicumarolic substances in the treatment of gynecological thromboembolism; thromboelastographic study of various anticoagulants].
    FERRARO C; STURA L
    Pathologica; 1955; 47(727-728):77-84. PubMed ID: 13322480
    [No Abstract]   [Full Text] [Related]  

  • 33. [ANTICOAGULANT THERAPY].
    GOOSSENS N
    Ther Ggw; 1963 Nov; 102():1247-58. PubMed ID: 14109351
    [No Abstract]   [Full Text] [Related]  

  • 34. [Anticoagulant medication. II. Heparin and synthetic heparinoids].
    RICHON J; LECONTE DES FLORIS R
    Concours Med; 1960 Oct; 82():4377-82. PubMed ID: 13741363
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of heparinoid in sclerotic degeneration of the fundus oculi. Experimental studies.
    MIETTINEN P; KYTILA J
    Ann Med Exp Biol Fenn; 1961; 39():75-8. PubMed ID: 13770432
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies by ultracentrifuge and paper electrophoresis on the effects of heparin and heparinoid substance on the lipoproteins in the serum of cholesterol-fed rabbits.
    NAKAMURA H; FUJITA H; OKUYAMA F
    Jpn J Physiol; 1956 Feb; 5(Suppl):375-81. PubMed ID: 13318784
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical efficacy of heparin fractions: issues and answers.
    Messmore HL
    Crit Rev Clin Lab Sci; 1986; 23(2):77-94. PubMed ID: 2419035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible causes of large local haemorrhages resulting from repeated intramuscular administration of the heparinoid Ro I-8307.
    den OTTOLANDER GJ; van DAM
    Folia Med Neerl; 1962 Jul; 5():112-8. PubMed ID: 14482793
    [No Abstract]   [Full Text] [Related]  

  • 39. [Modifications in various classes of lipoproteins produced by the admininistration of a heparinoid extracted from the duodenal mucosa].
    AZZENA D; ASTENGO F GHIGLIOTTI G
    Minerva Med; 1959 Jul; 50():2190-2. PubMed ID: 13795424
    [No Abstract]   [Full Text] [Related]  

  • 40. Heparanase modulates heparinoids anticoagulant activities via non-enzymatic mechanisms.
    Katz BZ; Muhl L; Zwang E; Ilan N; Herishanu Y; Deutsch V; Naparstek E; Vlodavsky I; Preissner KT
    Thromb Haemost; 2007 Dec; 98(6):1193-9. PubMed ID: 18064313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.